Treatment of Periodontitis by Tulsi Gel

Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age30-50
SponsorAl-Azhar University

About this trial

This study will be carried out to compare between the effect of 4%Tulsi gel and 1%Chlorohexidine gel as locally administered agents in the treatment of advanced periodontitis. Clinical parameters measurements, microbiological and radiographic assessment will be performed at base line, one month and 3 months after the intervention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients included in this study will be having advancedI Periodontitis

Aging from 30 to 50 years old

Free from any local or systemic risk factors that may affect the results of the study.

Disqualifiers

Long-term therapy with medications within a month prior to enrollment that could affect periodontal status or healing.

Pregnant woman and lactating mothers.

Patients with previous periodontal treatment including scaling and root planning and periodontal surgery in the last 3 and 6 months, respectively.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Tulsi gel

    Drug

    After scaling and root debridement, 4% of Tulsi gel will be injected in to the sulcus until it over flooded, at base line, then after one month.

  • Chlorhexidine gel

    Drug

    After scaling and root debridement, 1% of Chlorhexidine gel will be injected in to the sulcus until it over flooded, at base line, then after one month.

Treatment groups

24 Participants
are divided into 2 treatment groups
Group A: Tulsi Gel groupActive comparator 1 intervention
Group B: Chlorhexidine Gel groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Clinical parameters

Improvement of the clinical attachment loss in millimeters.

Time frame
3 months after end of treatment
2

Clinical parameters

Improvement of gingival index.

Time frame
3 months after end of treatment
3

Clinical parameters

Improvement of probing depth in millimeters.

Time frame
3 months after end of treatment

Secondary outcomes

1

Microbiological assessment

Counting microbial colony of Porphyromonas gingivalis

Time frame
3 months after end of treatment
2

Microbiological assessment

Counting microbial colony of Fusobacterium nucleatum

Time frame
3 months after end of treatment
3

Microbiological assessment

Counting microbial colony of Tannerella forsythia

Time frame
3 months after end of treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: